Guardion Health Sciences Inc

Guardion Health Sciences — Investor Presentation (December 2021)

17 slides from Guardion Health Sciences's investor presentation, Dec 8, 2021

  1. Slide 1: Shape the future with momentum

    Shape the future with momentum Guardion is a company. infused with motion and driven by innovation, working to improve quality of life through our clinical nutrition products. HEALTH SCIENCES December 2021

  2. Slide 2: Forward Looking Statement

    j Forward Looking Statement This presentation of Guardion Health Sciences, Inc. (the “company,” “Guardion,” “we,” “us,” or “our’) includes "forward-looking statements" intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. These st

  3. Slide 3: Corporate Overview

    Corporate Overview -” Guardion Health Sciences (Nasdaq: GHSI), is a Trading Symbol Nasdaq: GHSI clinical nutrition and diagnostics company that Market Capitalization ~$24M offers a portfolio of science-based, clinically- supported nutritional supplements, medical Recent Share Price $0.99 foods, and

  4. Slide 4: Clinical investment, strong brand

    Clinical investment Strong brand Scientific advisors Consumer-loved products Doctor education Marketing expertise Extensive Distribution Channels GUARDION

  5. Slide 5: Highlights

    Highlights Well-positioned to compete in the large and growing global nutrition market with differentiated and established product portfolio focused on bone, ocular, and immune health ** Well defined value creation process focused on clinical evidence, product development and targeted marketing ** S

  6. Slide 6: Nutrition Industry is Large and Growing

    Nutrition Industry is Large and Growing Global Supplement and Medical Food Market ** Increasing awareness of the importance of nutrition “* Growing body of research demonstrating benefits of nutrition ** Increasing geriatric population with unique nutritional needs “* Specific to eye care, consumer

  7. Slide 7: Well Defined Value Creation Process

    Well Defined Value Creation Process Science- / Customer PEECE Clinical Strong Product Targeted | Needs Evidence Claims Development Marketing |/ Formulation Understand the Create Execute clinical Identify product Create products Execute cost needs of science-based work on the claims based with a form

  8. Slide 8: Leveraging Clinical Evidence

    | Leveraging Clinical Evidence ** Guardion is leveraging and creating a science / evidence-based foundation through clinical studies to support our nutrition product portfolio + Investing in clinical research is fundamental to our model ** New placebo-controlled clinical study initiated on Glaucocet

  9. Slide 9: Viactiv is a Strong Growing Brand

    ’ Viactiv® is a Strong Growing Brand with Potential for Expansion GUARDION HEALTH SCIENCES 5

  10. Slide 10: Core Products Achieve Superior Consumer Experience and Distribution

    Core Products Achieve Superior Consumer Experience and Distribution Viactiv is a top brand in the calcium dietary supplement segment “ One of the fastest growing Calcium supplement brand, +8.6% YOY “» Increasing market share ($) to 5.7% (+0.7pt YOY) *» Strong distribution in nearly every top retail

  11. Slide 11: Viactiv and Organic Growth via Product Development

    Viactiv Calcium+ IMMUNE plus high potency Vitamin D to boost immune system and calcium absorption “* Zinc to support the immune system * New Orange Cream flavor “» Same base Calcium, * Clinically proven to increase protective macular pigment * Clinically proven to improve contrast sensitivity “» 3x

  12. Slide 12: Strong Leadership

    St e Leadership otrong @ | Bret Scholtes David W. Evans, PhD Craig J. Sheehan Jeff Benjamin Susan Klein, ND Chief Executive Officer Chief Science Officer Chief Commercial Officer Chief Accounting Officer Director of Board of Directors Board of Directors Medical Education é Robert N. Weingarten Mark

  13. Slide 13: Financial Highlights

    / Financial Highlights J “* Closed the Viactiv acquisition on June 1, 2021 “ For 3Q21, total revenue was $3.1 M; Viactiv’s contribution represented 95% of GHSI total sales * Cash and short-term investments at 9/30/21 was $10.6M and working capital was $12.9M; No debt on the balance sheet *» Viactiv®

  14. Slide 14: Strategic Priorities — Driving Growth and Creating Value

    ’ Strategic Priorities — Driving Growth and Creating Value Brand Strategy — developing a strategy that best leverages Viactiv’s strong consumer awareness and acceptance Product Strategy — focusing product portfolio on differentiated formulations, product taste, compelling product formats, and compet

  15. Slide 15: Potential Actions Over the Next Few Quarters

    Potential Actions Over the Next Few Quarters * Improve communications channels * Complete and implement the results of business unit and product evaluation « New product development and product launches * Cost reduction activities and optimizing internal processes + Ramp up of commercial activities

  16. Slide 16: Highlights

    Highlights Well-positioned to compete in the large and growing global nutrition market with differentiated and established product portfolio focused on bone, ocular, and immune health ** Well defined value creation process focused on clinical evidence, product development and targeted marketing ** S

  17. Slide 17: Guardion Health Sciences Investor Relations

    GUARDION HEALTH SCIENCES Investor Relations CORE IR Scott Arnold (516) 222-2560 Guardion Health Sciences is a clinical nutrition and diagnostics company that offers a portfolio of science-based, clinically- supported nutritional supplements, medical foods, and diagnostic products that support health

Guardion Health Sciences — Investor Presentation (December 2021) on 6ix